HK$31.46+143.50% · 3M
Moving avg
1W-10.17%
1M+67.79%
3M+143.50%
6M+175.24%
YTD+145.97%
1Y+85.06%
3Y+68.06%
5Y-14.51%
52-week range
$1.3282% of range$4.60
Company health
Value1/6
Growth6/6
Profitability2/6
Health4/6
Dividend0/6
Bull vs bear
Strengths
- Revenue compounding 27% a year
Risks
- Currently unprofitable
Key statistics
Valuation
Market cap
$8.77B
Enterprise value
$1.26B
P/E ratio (TTM)
-15.10x
P/S ratio (TTM)
11.67x
EV/EBITDA
49.83x
Per share & returns
EPS (TTM)
-$0.03714
Dividend yield
0.00%
Beta (1Y)
0.90
30-day change
+67.79%
Trading
Volume (24h)
98.68M
Previous close
HK$36.30
Shares outstanding
2.18B
About Genscript Biotech Corporation
Sector
Healthcare
Industry
Biotechnology
Exchange
HKEX
Symbol
1548.HK
Genscript Biotech Corporation is a mid-cap healthcare company in the Biotechnology industry.
Frequently asked questions
What is Genscript Biotech Corporation's market cap?
Genscript Biotech Corporation (1548.HK) has a market capitalization of $8.77B.
What sector is Genscript Biotech Corporation in?
Genscript Biotech Corporation operates in the Healthcare sector, Biotechnology industry.
What exchange does 1548.HK trade on?
1548.HK trades on HKEX.
Appears in
Eli Lilly and CompanyLLY
$1,148.20-0.98%
$1.08T cap
Johnson & JohnsonJNJ
$275.23-1.15%
$663.28B cap
AbbVie Inc.ABBV
$256.34-1.49%
$452.90B cap
Merck & Co., Inc.MRK
$150.34-1.31%
$371.31B cap
UnitedHealth Group IncorporatedUNH
$397.14-0.95%
$360.66B cap
Roche Holding AGSWX: ROP
CHF 357.00+0.14%
$350.91B cap
Novartis AGSWX: NOVN
CHF 129.58-1.33%
$304.13B cap
AstraZeneca PLCLON: AZN
£120.06-1.15%
$251.66B cap